Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07020559
PHASE4

Allogeneic vs Autologous PRP for Diabetic Wounds in Renal Dysfunction: a Randomized Controlled Trial

Sponsor: Peking University Third Hospital

View on ClinicalTrials.gov

Summary

Diabetic wounds are difficult to heal. Autologous platelets in diabetic patients with renal insufficiency have poor function. Allogeneic platelet plasma has a promising application prospect. Comparing the efficacy and safety differences between allogeneic platelet plasma and autologous platelet plasma is of significant importance and value for the clinical application.

Official title: Comparing Allogeneic Versus Autologous Platelet-Rich Plasma for Diabetic Wound Healing in Patients With Renal Dysfunction:a Randomized Controlled Trial

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

56

Start Date

2026-04

Completion Date

2028-05

Last Updated

2025-08-26

Healthy Volunteers

No

Interventions

DRUG

allogeneic platelet plasma

Al-PRP derived from healthy blood donors

DRUG

autologous platelet plasma

Autologous platelet-rich plasma from the patient themselves

Locations (1)

Peking University Third Hospital

Beijing, Beijing Municipality, China